US Critical Metals Corp
USCM
Three Valley Copper Corp
TVC.H
Windfall Geotek Inc
WIN
Revive Therapeutics Ltd
RVV
Global Hemp Group Inc
GHG
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 70.53%3.24B | 303.81%1.17B | -12,535.00%-2.49B | 30.18%5.61B | 272.32%3.4B | 0.80%1.9B | -85.43%289M | 104.25%20M | 332.15%4.31B | 145.70%914M |
Net income from continuing operations | 39.12%1.64B | 4.96%910M | 9.32%1.2B | 8.38%3.93B | -30.54%787M | 413.48%1.18B | -34.47%867M | 16.49%1.1B | -28.86%3.63B | -11.14%1.13B |
Operating gains losses | -185.52%-5.62B | -59.64%492M | 179.53%2.51B | -117.52%-4.66B | -1,783.70%-9.29B | 83.79%6.57B | -88.48%1.22B | -126.59%-3.16B | 1,521.84%26.58B | 121.82%552M |
Interest credited to policyholders’ deposits | -0.93%106M | 0.00%102M | 2.06%99M | 46.24%408M | 17.24%102M | 48.61%107M | 59.38%102M | 73.21%97M | 50.00%279M | 74.00%87M |
Other non cash items | 111.76%1.22B | 98.71%-12M | -176.25%-3.99B | 105.62%61M | 392.60%1.86B | -14.12%578M | -235.32%-931M | 20.66%-1.44B | 89.42%-1.09B | 86.70%-635M |
Change in working capital | 197.07%6.06B | 116.55%96M | -155.46%-2.05B | 129.26%7.11B | 15,612.12%10.24B | -148.76%-6.24B | 94.41%-580M | 132.55%3.69B | -1,071.45%-24.3B | -101.54%-66M |
-Change in loss and loss adjustment expense reserves | 13.64%100M | 34.21%102M | 39.44%99M | 117.76%331M | 92.00%96M | 95.56%88M | 145.16%76M | 173.08%71M | -93.71%152M | -98.84%50M |
-Change in other working capital | 194.14%5.96B | 99.09%-6M | -159.28%-2.15B | 127.73%6.78B | 8,843.10%10.14B | -147.83%-6.33B | 93.69%-656M | 131.85%3.62B | ---24.45B | ---116M |
Tax refund paid | 44.52%-167M | -8.51%-421M | 2.28%-257M | -55.97%-1.24B | -83.44%-288M | -89.31%-301M | -27.21%-388M | -51.15%-263M | 22.67%-795M | 49.84%-157M |
Cash from discontinued operating activities | ||||||||||
Operating cash flow | 70.53%3.24B | 303.81%1.17B | -12,535.00%-2.49B | 30.18%5.61B | 272.32%3.4B | 0.80%1.9B | -85.43%289M | 104.25%20M | 332.15%4.31B | 145.70%914M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 45.65%-75M | -251.56%-97M | 106.56%16M | 80.48%-559M | -91.27%-241M | -43.75%-138M | 102.47%64M | -369.23%-244M | -256.54%-2.86B | -147.19%-126M |
Net PPE purchase and sale | 28.26%-33M | 38.10%-26M | 35.29%-44M | -342.25%-172M | 60.98%-16M | -9.52%-46M | -124.28%-42M | -257.89%-68M | 187.65%71M | -86.36%-41M |
Net business purchase and sale | 106.25%2M | -99.41%1M | 102.27%3M | 91.97%-217M | -1,918.18%-222M | -1,700.00%-32M | 106.27%169M | -4,500.00%-132M | -512.70%-2.7B | 70.27%-11M |
Dividends received (cash flow from investment activities) | 111.11%19M | -13.04%20M | --121M | 18.52%32M | --0 | -55.00%9M | --23M | --0 | -92.93%27M | --0 |
Net other investing changes | 8.70%-63M | -6.98%-92M | -45.45%-64M | 22.01%-202M | 95.95%-3M | 9.21%-69M | -30.30%-86M | -2.33%-44M | 60.94%-259M | -111.43%-74M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 45.65%-75M | -251.56%-97M | 106.56%16M | 80.48%-559M | -91.27%-241M | -43.75%-138M | 102.47%64M | -369.23%-244M | -256.54%-2.86B | -147.19%-126M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -15.21%-1.64B | 61.11%-294M | -250.38%-925M | -4,246.48%-3.09B | 16.47%-639M | -569.95%-1.43B | -159.95%-756M | 25.42%-264M | 72.69%-71M | -163.64%-765M |
Net issuance payments of debt | -30.94%-931M | 474.10%621M | -144.49%-109M | -132.76%-610M | 109.61%22M | -390.20%-711M | -109.36%-166M | 240.28%245M | 39.16%1.86B | -111.67%-229M |
Net common stock issuance | 21.51%-146M | ---286M | ---174M | ---186M | --0 | ---186M | --0 | --0 | --0 | --0 |
Cash dividends paid | -6.62%-483M | -6.36%-502M | -7.11%-467M | -12.63%-1.88B | -20.32%-521M | -9.95%-453M | -9.01%-472M | -10.94%-436M | -17.02%-1.67B | -5.10%-433M |
Proceeds from stock option exercised by employees | -11.11%8M | --0 | -45.00%11M | 716.67%49M | 433.33%16M | 350.00%9M | --4M | 1,900.00%20M | -83.33%6M | -66.67%3M |
Interest paid (cash flow from financing activities) | 11.63%-76M | 9.32%-107M | -2.47%-83M | -50.00%-405M | -13.21%-120M | -95.45%-86M | -31.11%-118M | -170.00%-81M | -44.39%-270M | -92.73%-106M |
Net other financing charges | ---16M | -400.00%-20M | -758.33%-103M | -2,700.00%-52M | ---36M | ---- | -140.00%-4M | -200.00%-12M | -89.47%2M | --0 |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -15.21%-1.64B | 61.11%-294M | -250.38%-925M | -4,246.48%-3.09B | 16.47%-639M | -569.95%-1.43B | -159.95%-756M | 25.42%-264M | 72.69%-71M | -163.64%-765M |
Net cash flow | ||||||||||
Beginning cash position | 4.26%8.73B | -10.65%7.91B | 19.18%11.17B | 21.83%9.37B | -4.89%8.94B | 11.88%8.37B | 31.09%8.85B | 21.83%9.37B | -27.75%7.69B | 14.06%9.4B |
Current changes in cash | 354.03%1.52B | 292.56%776M | -595.90%-3.4B | 42.85%1.97B | 10,869.57%2.52B | -78.74%335M | -161.53%-403M | 44.36%-488M | 147.16%1.38B | 104.33%23M |
Effect of exchange rate changes | -119.82%-45M | 163.51%47M | 506.06%134M | -155.96%-169M | -528.26%-289M | -32.04%227M | -194.87%-74M | 48.44%-33M | 962.86%302M | -253.85%-46M |
End cash Position | 14.22%10.21B | 4.26%8.73B | -10.65%7.91B | 19.18%11.17B | 19.18%11.17B | -4.89%8.94B | 11.88%8.37B | 31.09%8.85B | 21.83%9.37B | 21.83%9.37B |
Free cash flow | 72.98%3.21B | 361.94%1.14B | -5,172.92%-2.53B | 26.19%5.44B | 270.57%3.39B | 0.60%1.85B | -87.54%247M | 90.20%-48M | 322.45%4.31B | 145.20%914M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.